货号 | 产品名称 | 规格 | 库存 | 价格 | 数量 | 购买 |
---|---|---|---|---|---|---|
KR0060 | RANK L/ TRANCE/ TNFSF11 (N-6His), Human, Recombinant | 10ug |
+
-
|
|
分子量 | 22.4 kDa |
---|---|
表观分子量 | 20 kDa |
片段与标签 | Ile140-Asp317 N-6His |
生物活性 | Measured by its ability to binding SF11A used funtional ELISAThe ED50 for this effect is less than 10 ug/ ml. |
物种 | Human |
表达宿主 | E.coli |
产品特性
纯度 | >90% as determined by reducing SDS-PAGE. |
---|---|
内毒素 | <1.0 EU per µg as determined by LAL test. |
保存 | Lyophilized Protein should be stored at < -20℃, though stable at room temperature for 3 weeks |
产品介绍
CD254, also known as RANKL, TNFSF11, TRANCE, OPGL and ODF, is a type II membrane Protein of the tumor necrosis factor (TNF) superfamily, and affects the immune system and control bone regeneration and remodeling. RANKL is the Ligand of nuclear factor (NF)-κB (RANK). When RANKL binds to RANK, it will undergo trimerization and then bind to an adaptor molecule TNF Receptor-associated factor 6 (TRAF6). This results in the activation of several downstream signaling cascades, including the NFκB, mitogen-activated Protein kinases (MAPK), activating Protein 1 (AP-1), and nuclear factor of activated T cells (NFATc1), resulting in the formation of multinucleated bone-resorbing osteoclasts. RANKL is widely expressed in skeletal muscle, thymus, liver, colon, small intestine, adrenal gland, osteoblast, mammary gland epithelial cells, prostate and pancreas.